Table 3 Associations between cardiac troponin I, cardiac troponin T and NT-proBNP and odds of maximum stage of AKI – excluding patients with confirmed MI

 Any AKI (1) vs no AKI (2)

62

56

0.12 (0.04–0.69)

0.02 (0.02–0.06)

1.50 (1.22–1.85)

<0.001

1.31 (1.05–1.63)

0.015

 Stage 3 AKI (1) vs lower stage (2)

40

78

0.17 (0.05–1.03)

0.03 (0.02–0.08)

1.41 (1.19–1.68)

<0.001

1.25 (1.01–1.56)

0.043

 Stage 3 AKI with RRT (1) vs lower stage (2)

34

84

0.17 (0.05–1.08)

0.04 (0.02–0.12)

1.35 (1.14–1.60)

0.001

1.12 (0.93–1.45)

0.199

 Any AKI (1) vs no AKI (2)

62

56

0.07 (0.03–0.15)

0.02 (0.01–0.04)

1.83 (1.42–2.35)

<0.001

1.55 (1.16–2.07)

0.003

 Stage 3 AKI (1) vs lower stage (2)

40

78

0.08 (0.04–0.19)

0.03 (0.01–0.06

1.69 (1.32–2.15)

<0.001

1.51 (1.10–2.09)

0.012

 Stage 3 AKI with RRT (1) vs lower stage (2)

34

84

0.08 (0.05–0.18)

0.03 (0.01–0.07)

1.55 (1.23–1.96)

<0.001

1.31 (0.94–1.84)

0.109

 Any AKI (1) vs no AKI (2)

62

56

7182 (2314–15,550)

1055 (192–2944)

1.47 (1.24–1.74)

<0.001

1.31 (1.06–1.61)

0.012

 Stage 3 AKI (1) vs lower stage (2)

40

78

9179 (2561–16,179)

1609 (320–6015)

1.49 (1.23–1.81)

<0.001

1.45 (1.12–1.86)

0.004

 Stage 3 AKI with RRT (1) vs lower stage (2)

34

84

10,105 (2617–17,069)

1681 (490–6416)

1.48 (1.21–1.81)

<0.001

1.43 (1.09–1.88)

0.011